Much to be thankful for this week in the world of biotech:
- Québec companies can be thankful for the province’s new $122 million biopharmaceutical strategy [1] that includes $30 million for genomics and a smattering of tax initiatives;
- Mimetogen can be thankful for its latest round of funding [2], and McGill University and the Lady Davis Institute for Medical Research can be thankful for a spin-out that’s successful so far; and
- In Toronto, we can be thankful for a fantastic round of conferences coming up: the OGI/IDT Synthetic Biology Conference [3], the 50th Anniversary Celebrations for the Gairdner Awards [4], and the Canadian Science Policy Conference [5].
Whether it’s a white or dark cut you’re looking for, head over to the Cross-Border Biotech Blog [6] or follow us on Twitter @crossborderbio [7] for second helpings.